Compare PRPO & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRPO | JTAI |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4M | 6.9M |
| IPO Year | N/A | N/A |
| Metric | PRPO | JTAI |
|---|---|---|
| Price | $24.05 | $1.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 14.7K | ★ 103.3K |
| Earning Date | 11-14-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $22,800,000.00 | $10,584,279.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $433.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.95 | N/A |
| 52 Week Low | $3.90 | $1.40 |
| 52 Week High | $28.50 | $11.77 |
| Indicator | PRPO | JTAI |
|---|---|---|
| Relative Strength Index (RSI) | 55.72 | 35.90 |
| Support Level | $22.50 | $1.40 |
| Resistance Level | $26.00 | $1.76 |
| Average True Range (ATR) | 2.01 | 0.17 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 52.44 | 27.04 |
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as through Jet Token's leased and managed aircraft.